Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Stupp

Showing results (51-60 of 73) with videos related to

Pageof 8
Sort By:
European Journal of Cancer (Oxford, England : 1990)|May 26, 2023
Association of pre-radiotherapy tumour burden and overall survival in newly diagnosed glioblastoma adjusted for MGMT promoter methylation statusA Alafandi, K A van Garderen, S Klein, et al.
Lung Cancer (Amsterdam, Netherlands)|September 21, 2000
Phase II study of docetaxel in the treatment of patients with advanced non-small cell lung cancer in routine daily practiceK Mattson, L Bosquee, G Dabouis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 1998
Phase I study of concomitant chemoradiotherapy with paclitaxel, fluorouracil, and hydroxyurea with granulocyte colony-stimulating factor support for patients with poor-prognosis cancer of the head and neckB Brockstein, D J Haraf, K Stenson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 14, 2006
Intra-arterial hepatic fotemustine for the treatment of liver metastases from uveal melanoma: experience in 101 patientsS Peters, V Voelter, L Zografos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 22, 2007
Multicenter phase II trial of gefitinib first-line therapy followed by chemotherapy in advanced non-small-cell lung cancer (NSCLC): SAKK protocol 19/03G D'Addario, D Rauch, R Stupp, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2007
Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesotheliomaW Weder, R A Stahel, J Bernhard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 28, 2003
Phase II study of first-line chemotherapy with temozolomide in recurrent oligodendroglial tumors: the European Organization for Research and Treatment of Cancer Brain Tumor Group Study 26971M J van den Bent, M J B Taphoorn, A A Brandes, et al.
European Journal of Neurology|August 20, 2010
Guidelines on management of low-grade gliomas: report of an EFNS-EANO Task ForceR Soffietti, B G Baumert, L Bello, et al.
British Journal of Cancer|July 5, 2007
The prognostic value of health-related quality-of-life data in predicting survival in glioblastoma cancer patients: results from an international randomised phase III EORTC Brain Tumour and Radiation Oncology Groups, and NCIC Clinical Trials Group studyM Mauer, R Stupp, M J B Taphoorn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2001
Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapseM Brada, K Hoang-Xuan, R Rampling, et al.
Pageof 8

Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
European Journal of Cancer (Oxford, England : 1990)|May 26, 2023
Association of pre-radiotherapy tumour burden and overall survival in newly diagnosed glioblastoma adjusted for MGMT promoter methylation statusA Alafandi, K A van Garderen, S Klein, et al.
Lung Cancer (Amsterdam, Netherlands)|September 21, 2000
Phase II study of docetaxel in the treatment of patients with advanced non-small cell lung cancer in routine daily practiceK Mattson, L Bosquee, G Dabouis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 1998
Phase I study of concomitant chemoradiotherapy with paclitaxel, fluorouracil, and hydroxyurea with granulocyte colony-stimulating factor support for patients with poor-prognosis cancer of the head and neckB Brockstein, D J Haraf, K Stenson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 14, 2006
Intra-arterial hepatic fotemustine for the treatment of liver metastases from uveal melanoma: experience in 101 patientsS Peters, V Voelter, L Zografos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 22, 2007
Multicenter phase II trial of gefitinib first-line therapy followed by chemotherapy in advanced non-small-cell lung cancer (NSCLC): SAKK protocol 19/03G D'Addario, D Rauch, R Stupp, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2007
Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesotheliomaW Weder, R A Stahel, J Bernhard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 28, 2003
Phase II study of first-line chemotherapy with temozolomide in recurrent oligodendroglial tumors: the European Organization for Research and Treatment of Cancer Brain Tumor Group Study 26971M J van den Bent, M J B Taphoorn, A A Brandes, et al.
European Journal of Neurology|August 20, 2010
Guidelines on management of low-grade gliomas: report of an EFNS-EANO Task ForceR Soffietti, B G Baumert, L Bello, et al.
British Journal of Cancer|July 5, 2007
The prognostic value of health-related quality-of-life data in predicting survival in glioblastoma cancer patients: results from an international randomised phase III EORTC Brain Tumour and Radiation Oncology Groups, and NCIC Clinical Trials Group studyM Mauer, R Stupp, M J B Taphoorn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2001
Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapseM Brada, K Hoang-Xuan, R Rampling, et al.
Pageof 8